ACRX AcelRx Pharmaceuticals Inc.

2.27
+0.06  (+3%)
Previous Close 2.21
Open 2.22
Price To Book -9.87
Market Cap 180,318,680
Shares 79,435,542
Volume 594,771
Short Ratio
Av. Daily Volume 1,325,979

NewsSee all news

  1. AcelRx Pharmaceuticals Selected to Present at the 2019 Military Health System Research Symposium
  2. Edited Transcript of ACRX earnings conference call or presentation 5-Aug-19 9:00pm GMT
  3. AcelRx Pharmaceuticals Inc (ACRX) Q2 2019 Earnings Call Transcript
  4. AcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Misses Revenue Estimates
  5. AcelRx Pharmaceuticals Reports Second Quarter 2019 Financial Results

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data released August 15 2016
ARX-04 (SAP302)
Patients who presented to emergency departments with moderate-to-severe acute pain associated with trauma or injury
FDA Approval announced November 2, 2018.
DSUVIA (ARX-04)
Moderate-to-severe acute pain following a surgical procedure
CRL Jul 26 2014. NDA resubmission timing to be known in 2H 2019.
Zalviso
Post-operative pain following open abdominal surgery and hip or knee replacement surgery

Latest News

  1. AcelRx Pharmaceuticals Selected to Present at the 2019 Military Health System Research Symposium
  2. Edited Transcript of ACRX earnings conference call or presentation 5-Aug-19 9:00pm GMT
  3. AcelRx Pharmaceuticals Inc (ACRX) Q2 2019 Earnings Call Transcript
  4. AcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Misses Revenue Estimates
  5. AcelRx Pharmaceuticals Reports Second Quarter 2019 Financial Results
  6. AcelRx to announce second quarter 2019 results and provide an update on the company's business on Monday, August 5th, 2019
  7. Analysts Estimate AcelRx Pharmaceuticals (ACRX) to Report a Decline in Earnings: What to Look Out for
  8. What's in the Cards for AcelRx (ACRX) This Earnings Season?
  9. AcelRx added to the Russell 2000® and 3000® indexes
  10. Hedge Funds Have Never Been More Bullish On AcelRx Pharmaceuticals Inc (ACRX)
  11. Concert Pharma's CTP-692 Positive for Schizophrenia in Phase I
  12. Edited Transcript of ACRX earnings conference call or presentation 8-May-19 8:30pm GMT
  13. AcelRx announces the closing of a $25 million senior secured debt facility
  14. AcelRx Pharmaceuticals (ACRX) Upgraded to Buy: Here's Why
  15. Here's Why AcelRx Pharmaceuticals Fell as Much as 14% Today
  16. AcelRx Pharmaceuticals (ACRX) Reports Q1 Loss, Lags Revenue Estimates
  17. AcelRx Pharmaceuticals: 1Q Earnings Snapshot
  18. AcelRx Pharmaceuticals, Inc. to Host Earnings Call